StockStory Taps Zoetis (ZTS) as Top Healthcare Pick, Warns on ITGR and LFST

An analysis by StockStory on June 1, 2026, identified Zoetis (NYSE:ZTS) as a standout healthcare buy while advising caution on Integer Holdings (NYSE:ITGR) and LifeStance Health (NASDAQ:LFST) amid a sector that has trailed the broader market. Zoetis, the world’s largest pure-play animal health company, traded at $77.89 per share, representing a forward price-to-earnings ratio of 11.2x. The report pointed to the stock’s attractive valuation and resilient earnings profile. In contrast, Integer Holdings fetched $90 per share, or 14.1x forward P/E, and LifeStance Health commanded $7.71 per share at 22.9x forward P/E—levels StockStory deemed risky. Healthcare stocks have collectively gained just 3.8% over the past six months, compared to the S&P 500’s 10.9% rise, dragged by COVID inventory destocking and other short-term pressures. StockStory’s analysis suggests Zoetis can generate consistent earnings growth despite the sector’s headwinds, while ITGR and LFST carry more uncertainty.